Immunoregulation by capsular components of Cryptococcus neoformans.
about
Cryptococcus-Related Immune Reconstitution Inflammatory Syndrome (IRIS): Pathogenesis and its Clinical ImplicationsPaucity of initial cerebrospinal fluid inflammation in cryptococcal meningitis is associated with subsequent immune reconstitution inflammatory syndromeMolecular mechanisms of cryptococcal meningitisFunctional analysis of host factors that mediate the intracellular lifestyle of Cryptococcus neoformansA role for LHC1 in higher order structure and complement binding of the Cryptococcus neoformans capsuleDirect inhibition of T-cell responses by the Cryptococcus capsular polysaccharide glucuronoxylomannan.Cas3p belongs to a seven-member family of capsule structure designer proteins.Involvement of glycoreceptors in galactoxylomannan-induced T cell death.Phenotypic switching of Cryptococcus neoformans can produce variants that elicit increased intracranial pressure in a rat model of cryptococcal meningoencephalitisMelanization of Cryptococcus neoformans affects lung inflammatory responses during cryptococcal infection.Phase I evaluation of the safety and pharmacokinetics of murine-derived anticryptococcal antibody 18B7 in subjects with treated cryptococcal meningitis.Cryptococcus neoformans responds to mannitol by increasing capsule size in vitro and in vivo.Dual infections with pigmented and albino strains of Cryptococcus neoformans in patients with or without human immunodeficiency virus infection in IndiaEffect of amphotericin B on capsule and cell size in Cryptococcus neoformans during murine infectionThe common Cryptococcus neoformans glucuronoxylomannan M2 motif elicits non-protective antibodies.The vacuolar-sorting protein Snf7 is required for export of virulence determinants in members of the Cryptococcus neoformans complex.Effects of voriconazole on Cryptococcus neoformans.Antibody to Cryptococcus neoformans glucuronoxylomannan inhibits the release of capsular antigenMannoprotein from Cryptococcus neoformans promotes T-helper type 1 anticandidal responses in mice.Susceptibility of Cryptococcus neoformans biofilms to antifungal agents in vitroEffect of virulence factors on the photodynamic inactivation of Cryptococcus neoformans.Antibodies produced in response to Cryptococcus neoformans pulmonary infection in mice have characteristics of nonprotective antibodiesGlucuronoxylomannan, galactoxylomannan, and mannoprotein occupy spatially separate and discrete regions in the capsule of Cryptococcus neoformans.Pathogenic yeasts deploy cell surface receptors to acquire iron in vertebrate hosts.Multiple Disguises for the Same Party: The Concepts of Morphogenesis and Phenotypic Variations in Cryptococcus neoformansCryptococcus neoformans cells in biofilms are less susceptible than planktonic cells to antimicrobial molecules produced by the innate immune system.Capsule enlargement in Cryptococcus neoformans confers resistance to oxidative stress suggesting a mechanism for intracellular survival.Vesicular polysaccharide export in Cryptococcus neoformans is a eukaryotic solution to the problem of fungal trans-cell wall transport.Human immunoglobulin G2 (IgG2) and IgG4, but not IgG1 or IgG3, protect mice against Cryptococcus neoformans infection.Adaptation of Cryptococcus neoformans to mammalian hosts: integrated regulation of metabolism and virulence.Parallel beta-helix proteins required for accurate capsule polysaccharide synthesis and virulence in the yeast Cryptococcus neoformans.Cryptococcus neoformans biofilm formation depends on surface support and carbon source and reduces fungal cell susceptibility to heat, cold, and UV lightThe relative susceptibility of mouse strains to pulmonary Cryptococcus neoformans infection is associated with pleiotropic differences in the immune response.Phenotypic switching of Cryptococcus neoformans occurs in vivo and influences the outcome of infectionCryptococcal genotype influences immunologic response and human clinical outcome after meningitis.Advances in combating fungal diseases: vaccines on the thresholdMethamphetamine enhances Cryptococcus neoformans pulmonary infection and dissemination to the brain.Cytokine and inducible nitric oxide synthase mRNA expression during experimental murine cryptococcal meningoencephalitis.Glycoconjugates and polysaccharides of fungal cell wall and activation of immune systemProtective immunity against cryptococcus neoformans infection.
P2860
Q24629367-BAA5217D-A9C6-4901-A4FD-E731A37464CBQ24630287-00396D46-9D36-4C42-9298-FCC68B849C57Q24632155-A259401A-EE50-4496-977E-3F902FCEE9E1Q27349729-C08B5218-DC46-4968-B5EB-E2125B3F1194Q28538344-3B0AD311-AE09-44BB-B4DF-AB97EC45686AQ33263249-D21F4238-AD44-47DA-85AF-686C7B60F025Q33560210-9641EC8F-E7BA-400B-B2CB-444EF8B3D34DQ33715053-DA308C5F-C9C7-4773-9A4F-A43156DA47C4Q33716133-48CD3CA4-57CB-43A3-AA24-3A0FCD3D4520Q33769483-B01FD673-28A8-4017-B84D-0A533BAC9890Q33857658-9BE4BB00-1093-4349-A3B0-1DDA06A1FD50Q33939999-9A650196-0506-425A-B6F9-D76C19998C5FQ34042463-D6FB18A9-A44D-437C-BC49-A7AFAB80B5E9Q34077152-73AF896D-9C6B-40F1-83ED-29AA0DE6F8BFQ34099803-1E91E0B8-EBF1-41A6-BB93-B5AF4212943DQ34117064-7CBDC8C5-C3A9-48D1-9EDF-EFDCD9CA656DQ34142180-9C0B31F8-6B86-47D5-A78B-1CB3F8C9CF9DQ34146715-68DC216C-7410-4090-A6EC-C491C09E6978Q34259300-CFDA8262-5946-4C83-AE0A-BD0E8F28538BQ34509773-270AE107-9EB7-4710-962D-F19D60810119Q34563021-92B31C1D-A0E0-451B-96A0-2F582B9F1223Q34757345-CE2B1A1D-922D-4A68-AF6A-24A21E7D2D9EQ34775729-FEF87D34-1AC8-4892-9494-539FF96972DBQ34979350-6ED21D54-C3D3-4802-856F-A225A30CA66EQ35197055-04028DBE-5BDD-4B33-B72A-86DFB73BFCF3Q35217511-A39F5139-A496-48CF-981D-E9BE1A3A1187Q35512999-4C04A904-916A-4F4F-9508-B0FA5DD9AB73Q35641043-054315F4-6F20-472E-B2B8-759EEDC88639Q35689463-E26FA686-07AF-4B22-9031-8352D54DDB07Q35739013-C2E30D2A-87E4-4F52-9863-F9DDE7C01197Q35783648-29844440-77DD-41EE-8E68-400AF096F773Q35913297-F52DFD9E-3741-49AC-9AF5-DB2DB76603CBQ35913526-DE0C7C48-81FD-4EB9-A435-BEBD09A230BAQ36042949-2C7F4991-2E82-43A6-BD1B-E4C88289AC0FQ36250573-24E76261-DEDA-4FA8-BEC3-127CED2528B6Q36406460-44153202-3AF1-44C7-96CF-2A9791449D4CQ37074706-284B36A9-6A70-4B83-BDCF-7A07D643C493Q37115803-8741F934-63C1-4112-B434-3F2678E92BAAQ37159154-DF13E0F5-D2EF-4126-BB21-BC69E3DD3D46Q37181729-15206B87-C35B-44B4-A90F-9E22F78094D2
P2860
Immunoregulation by capsular components of Cryptococcus neoformans.
description
2000 nî lūn-bûn
@nan
2000 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Immunoregulation by capsular components of Cryptococcus neoformans.
@ast
Immunoregulation by capsular components of Cryptococcus neoformans.
@en
Immunoregulation by capsular components of Cryptococcus neoformans.
@nl
type
label
Immunoregulation by capsular components of Cryptococcus neoformans.
@ast
Immunoregulation by capsular components of Cryptococcus neoformans.
@en
Immunoregulation by capsular components of Cryptococcus neoformans.
@nl
prefLabel
Immunoregulation by capsular components of Cryptococcus neoformans.
@ast
Immunoregulation by capsular components of Cryptococcus neoformans.
@en
Immunoregulation by capsular components of Cryptococcus neoformans.
@nl
P2860
P356
P1433
P1476
Immunoregulation by capsular components of Cryptococcus neoformans
@en
P2093
A Vecchiarelli
P2860
P304
P356
10.1080/MMY.38.6.407.417
P577
2000-12-01T00:00:00Z